News for hackers. Stuff that matters.
Re:Total cholesterol and all-cause mortality – a study among... by Amygaz on Sunday June 09, 2019 @09:25AM (#20139026)
I tend to disagree.

We actually can measure the biological age. There are clinical biomarkers for that. It is not commonly done. The best one, epigenetic signature, is yet to be clinically approved or widely available.

Now, in that paper, they use broad range of age as a descriptor, confounding many age-associated phenotype and genotypes, which also translate into risk factors. You can definitely say that the 18-34 cohort is different 45-54, and that the later as more risk factors, the same a specific mutation might be associated with higher or even guaranteed chance of developing a disease, and hence will be use as a biomarker.

That being said, it is not typical to measure the biological age of healthy individuals. Actually, we don't know what an healthy individual is. We know a great deal more about diseased individuals. The current status seems to be that if you are not diseased you are healthy. I don't agree with that. That's how science is done. And that is how we end up with half-baked studies in one of the most impactful journal .

Re:Total cholesterol and all-cause mortality – a study among... by naasking on Sunday June 09, 2019 @10:01AM (#20139234)
> We actually can measure the biological age. There are clinical biomarkers for that. It is not commonly done. The best one, epigenetic signature, is yet to be clinically approved or widely available.

What is the precision and accuracy of the best biomarker? ie. if I gave you the necessary sample, how close can you get to the correct age and what are the error bars?